VRS
TCRT icon

Virginia Retirement Systems’s Alaunos Therapeutics TCRT Stock Holding History

Virginia Retirement Systems’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-105
Closed -$42K – 1032
2014
Q3 		$42K Sell
105
-6
-5% -$2.89K ﹤0.01% 957
2014
Q2 		$67K Sell
111
-8
-7% -$4.45K ﹤0.01% 949
2014
Q1 		$82K Hold
119
– – ﹤0.01% 946
2013
Q4 		$78K Buy
+119
New +$70.9K ﹤0.01% 857

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virginia Retirement Systems's TCRT Position: Q4 2014 in Review

Virginia Retirement Systems sold out of Alaunos Therapeutics (TCRT) in Q4 2014, closing a stake of 105 shares — an estimated $42K sold.

Virginia Retirement Systems first reported a position in TCRT in Q4 2013 and held it in 4 quarters. The position peaked at $82K in Q1 2014. 85 funds tracked by Wall St. Rank hold TCRT as of Q4 2014.

  • Virginia Retirement Systems reported no remaining Alaunos Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Virginia Retirement Systems sold 105 Alaunos Therapeutics shares in Q4 2014, an estimated $42K.
  • Virginia Retirement Systems first reported a position in Alaunos Therapeutics in Q4 2013 and held it in 4 quarters.
  • Virginia Retirement Systems's Alaunos Therapeutics position peaked at $82K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2014.

Based on Virginia Retirement Systems's 13F filing for Q4 2014, filed 28 Jan 2015.